AK
Akanda Corp.
AKAN · NASDAQ
$3.07 -0.65% (-$0.02)
1M -52.40%
Market Cap $97.1K
P/E Ratio -
Div. Yield -
ROE 1,202.24%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.12x
P/B 0.02x
P/E N/A
Growth
100 /100
Growing Rev. growth 172.32%
EPS growth N/A
FCF growth N/A
Profitability
8 /100
Weak Gross margin 24.91%
Net margin 489.57%
Op. margin 523.80%
Quality
1 /100
Poor ROIC 94.67%
ROE 1,202.24%
ROA 51.76%
Debt
61 /100
Moderate Debt/Equity 0.08x
Current ratio 1.39x
Int. coverage -31.65x
Stability
4 /100
Unstable Beta 1.73x
Rev. volatility 3,615.67%
EPS volatility 9,796.97%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AKAN
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Katharyn Field
Employees
8
Headquarters
Toronto